Task X9: Development of Standardized Filovirus Immune Assays and Reagents
$655,386N01FY2018AINIH
Battelle Centers/Pub Hlth Res & Evaluatn, Columbus OH
Investigators
Abstract
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases. .
View original record on NIH RePORTER →